dockets: FDA-2003-P-0408

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

This data as json

id	agency_id	title	docket_type	last_modified	object_id
FDA-2003-P-0408	FDA	to request the commissioner of Food and Drugs to determine that Lovenox(enoxaparin sodlium),NDA 20-164(90mg/0.6ml)Product Number 006),sponsored by Aventis Pharmaceuticals Inc.(Aventis), was not withdrawn from sale for reasons of safety of effectiveness.	Nonrulemaking	2021-09-01T01:03:18Z	0b000064804a1af4

Links from other tables